AzurRx BioPharma Announces First Patients Dosed in Phase 2b OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis
First three patients enrolled in dose escalation trial using delayed-release enteric capsulesTopline data expected in 1H 2021NEW YORK, Aug. 13, […]